Reuters: Drugmakers kick off 2021 with 500 U.S. price hikes
(From Reuters)
The hikes come as drugmakers are reeling from effects of the COVID-19 pandemic, which has reduced doctor visits and demand for some drugs. They are also fighting new drug price-cutting rules from the Trump administration, which would reduce the industry’s profitability.
This article was originally posted here: https://www.ac2news.com/2021/01/reuters-drugmakers-kick-off-2021-with-500-u-s-price-hikes/.
